Pancreatic Cancer
Entity.
- Evidence
- 140 documents · 67 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 Jan 2026, last seen 6 Oct 2026
- Measured
- 16% of mentions say something specific about it; the rest only name it
- As of
- 6 Oct 2026
Where this comes from
- Latest Science News -- ScienceDaily · 2026-10-04 · Vitamin D drug may help crack pancreatic cancer’s protective shield (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-10-01 · The VIRAGE Trial Cracked the Pancreatic Cancer Wall. Now the Hard Question Is Whether the Field Can Read the Blueprint. (opens the source in a new tab)
- Nature Medicine · 2026-09-30 · Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial (opens the source in a new tab)
- Medical Daily · 2026-09-30 · Five Radiation Sessions Before Pancreatic Cancer Surgery Preserved Physical Function, but Survival Was Numerically Lower in Small Trial (opens the source in a new tab)
- Expert Opin Biol Ther · 2026-09-28 · Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer. (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-26 · Annamycin Shows Immune Activation in Pancreatic Cancer Preclinical Study (opens the source in a new tab)
- European Medical Journal · 2026-09-25 · Pancreatic Cancer Mortality Remains Unequal Across Japan (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-25 · Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer (opens the source in a new tab)
- Inside Precision Medicine · 2026-09-24 · New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer (opens the source in a new tab)
- GEN - Genetic Engineering & Biotechnology News · 2026-09-24 · Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models (opens the source in a new tab)
- Eur J Med Chem · 2026-09-24 · Design, synthesis, and structural optimization of novel pan-KRAS degrader for the treatment of KRAS-mutant pancreatic cancer. (opens the source in a new tab)
- KRAS Mutation Research (Google News) via Google News · 2026-09-24 · Dana-Farber Study Finds New Strategy to Turn Short-Lived KRAS Response into Durable Pancreatic Cancer Remission - trialsitenews.com (no link on file)